The Relationship Between CCK and Seizure Susceptibility
wu Yue,Zhang Wanqin(Department of Physiology, Dalian Medical University, Dalian, 116027)
Abstract:Kainic acid (KA) 10mg/kg was subcutaneously injected to sprague-Dawley rats and induced acute convulsions. A week later, subconvulsive dose of KA (5mg/kg) was used to detect the seizure susceptibility. At the same time, by immunocytochemistry and hybridization, PCCK mRNA was found increased significantly in frontal cortex of susceptible rats. The CCK-IR was enhanced in pyramidal cells near the DGCs of hippocampus and was decreased obviously in the deep region of hilus. These changes were not observed in nonsusceptible rats, which may be relevant to development of seizure susceptibility.
Keywords:kainic acid; frontal cortex; hippocampus; seizure susceptibility; CCK参考文献:
[1]Dodd J, Kelly JS. The actions of cholecystokinin and related peptides on pyramidal neurons of the mammalian hippocampus. Brain res, 1981, 205: 337
[2]Harro J, Vasar E, Bradwejn J. CCK in animal and human research on anxiety. Tips, 1993, 14: 244
[3]Meyer DK, Widmann R, Sperk G. Increased brain levels of cholecystokinin octapeptide after kainic acid-induced seizures in the rat. Neuroscience Letters, 1986, 69: 208
[4]Buckmaster PS, Dudek FE. Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrna of epileptic kainate-treated rats. J Comp Neurol, 1997, 385: 385
[5]Racine RJ. Modification of seizure activity by electrical stimulation, Ⅱ. Motor seizure. Electroencephalogr Clin neurophysiol, 1972, 32: 281
[6]Wank SA, Pisegna JR, Weerth AD. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA, 1992, 89: 8691
[7]Shinohara S, Katsuura G, Eigyo M, et al. Inhibitory effect of CCK-8 and ceruletide on glutamate-induced rises in intracellular free calcium concentrations in rat neuron cultures. Brain res, 1992, 588: 223
[8]Schwarzer C, Williamson JM, Lothman EW, et al. Somatostatin, Neuropeptide Y, Neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience, 1995, 69: 831
[9]Schwarzer C, Sperk G, Samanin RR, et al. Neuropeptidesimmunoreactivity and their mRNA expression inkindling: functional implications for limbic epileptogenesis. Brain Res Reviews, 1996, 22: 27
